Alnylam Pharmaceuticals, Inc. (LON: 0HD2)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	27,914	18,858	24,266	14,979	11,060	9,695
Market Cap Growth	45.22%	-22.29%	62.00%	35.43%	14.08%	67.75%
Enterprise Value	27,870	19,060	24,537	14,677	10,722	8,626
Last Close Price	213.86	151.59	191.34	119.22	99.03	91.61
PS Ratio	16.86	13.14	28.18	24.02	30.64	58.43
PB Ratio	1091.32	-108.87	-184.79	34.48	14.86	8.92
P/TBV Ratio	1091.32	-	-	34.48	14.86	8.92
P/FCF Ratio	2198.13	572.67	-	-	-	-
P/OCF Ratio	624.32	230.62	-	-	-	-
EV/Sales Ratio	16.39	13.28	28.50	23.54	29.70	51.99
EV/FCF Ratio	2325.47	578.81	-	-	-	-
Debt / Equity Ratio	84.26	-12.16	-16.51	3.72	1.57	0.21
Debt / FCF Ratio	169.72	63.96	-	-	-	-
Asset Turnover	0.52	0.50	0.29	0.24	0.17	0.11
Inventory Turnover	3.57	2.85	1.57	1.73	1.19	0.62
Quick Ratio	2.57	2.86	3.16	3.79	4.23	4.48
Current Ratio	2.75	3.08	3.51	4.04	4.47	4.87
Return on Equity (ROE)	-	-	-526.14%	-106.31%	-69.92%	-64.66%
Return on Assets (ROA)	-2.92%	-4.78%	-13.65%	-12.56%	-17.85%	-29.58%
Return on Capital (ROIC)	-4.47%	-7.17%	-18.77%	-16.46%	-23.80%	-38.19%
Earnings Yield	-0.89%	-1.83%	-3.87%	-4.20%	-5.68%	-6.90%
FCF Yield	0.04%	0.17%	-2.10%	-3.54%	-4.54%	-3.26%
Buyback Yield / Dilution	-1.97%	-2.64%	-2.73%	-3.01%	-5.24%	-8.62%
Total Shareholder Return	-1.97%	-2.64%	-2.73%	-3.01%	-5.24%	-8.62%

Source: S&P Capital IQ. Standard template. Financial Sources.